140 related articles for article (PubMed ID: 10943859)
1. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.
Dreja H; Annenkov A; Chernajovsky Y
Arthritis Rheum; 2000 Aug; 43(8):1698-709. PubMed ID: 10943859
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
[TBL] [Abstract][Full Text] [Related]
4. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
5. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis.
Myers LK; Kang AH; Postlethwaite AE; Rosloniec EF; Morham SG; Shlopov BV; Goorha S; Ballou LR
Arthritis Rheum; 2000 Dec; 43(12):2687-93. PubMed ID: 11145026
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
7. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
8. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S
Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945
[TBL] [Abstract][Full Text] [Related]
9. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
Blom AM; Nandakumar KS; Holmdahl R
Ann Rheum Dis; 2009 Jan; 68(1):136-42. PubMed ID: 18276745
[TBL] [Abstract][Full Text] [Related]
10. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
11. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of collagen arthritis.
Brand DD; Kang AH; Rosloniec EF
Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
14. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
Hida S; Miura NN; Adachi Y; Ohno N
J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
[TBL] [Abstract][Full Text] [Related]
15. Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis.
Kageyama Y; Koide Y; Uchijima M; Nagata T; Yoshida A; Taiki A; Miura T; Nagafusa T; Nagano A
Arthritis Rheum; 2004 Mar; 50(3):968-75. PubMed ID: 15022341
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
18. The Y chromosome-linked "autoimmune accelerating" yaa gene suppresses collagen-induced arthritis.
Jansson L; Holmdahl R
Eur J Immunol; 1994 May; 24(5):1213-7. PubMed ID: 8181531
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model.
Chernajovsky Y; Adams G; Triantaphyllopoulos K; Ledda MF; Podhajcer OL
Gene Ther; 1997 Jun; 4(6):553-9. PubMed ID: 9231071
[TBL] [Abstract][Full Text] [Related]
20. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
